Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Bacitracin manufacturers

Filters

Filters

Filters , active

Country of origin : India

Clear all

None products found

polymyxin b + bacitracin + neomycin sulfate

Cream 5000 units, 400 units, 3400 units

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17459
This pharmaceutical company is a rapidly growing force in the global healthcare market, specializing in high-quality, affordable medications. They boast a diverse product portfolio encompassing prescription drugs, over-the-counter medications, and supplements, targeting key therapy areas like anti-Alzheimer's, asthma, diabetes, and cardiovascular health. The company holds WHO-GMP certifications and international approvals, underscoring their commitment to quality and regulatory compliance. Their manufacturing facilities are equipped with state-of-the-art technology, ensuring the production of safe and effective medicines. They distribute their products widely across multiple regions, including South East Asia and the Middle East, leveraging a robust network of distributors and consignees. Their mission is to provide accessible and affordable healthcare solutions worldwide, aiming to be a trusted partner for high-quality pharmaceuticals globally.

Manufacturer usually replies in 2 days

neomycin + polymyxin b sulfate + bacitracin

Ointment 3.5 mg + 5000 units + 400 units

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #13225

It is an Indian manufacturer that is active in 40+ countries. They are in this line of business for 85+ years. The company has a more than $150 million turnover. The company manufactures and distributes more than 100 APIs and 200 formulations which is responsible for 25000+ SKUs. Quality control and quality assurance are one of the focus areas for the company.

Manufacturer usually replies in 14 days

neomycin + bacitracin + sulfacetamide

Cutaneous powder 3400 IU + 5000 IU + 400 IU

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #38728

Established in 2012, this Manufacturer is a CTD dossier owner and manufacturer and GMP manufacturer with products sold in over 39 countries across four continents. With multiple WHO-GMP and other regulatory approvals (e.g., Ghana FDA, Philippines FDA, Kenya PBB, Tanzania TFDA, Nigeria NAFDAC), it operates several finished dosage and R&D production lines (tablets, capsules, injectables, liquids, softgels, effervescent, suppositories). As a CTD dossier owner and manufacturer, it supports regulatory filings worldwide. Headquartered in India and employing a global workforce, it serves diverse markets as a CTD dossier owner and manufacturer and GMP manufacturer.

Manufacturer usually replies in 17 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Polymyxin B is an antibiotic used to treat bacterial infections, such as meningitis, pneumonia, sepsis. Although manufacturing companies use polymyxin B as a standalone drug, it is more commonly used in combination drug formulations, along with other active ingredients such as lidocaine, neomycin, bacitracin, diperodon, hydrocortisone, as well as many others. Polymyxin B suppliers market the standalone medication in the form of powders for injectable solutions. In medical use for over 50 years, polymyxin B has since become included in the WHO’s list of Essential Medicines that contains the most important drugs recommended for a basic health system. Polymyxin B suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified polymyxin B manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.